Browse

It's tough to write nuanced headlines, but a new study on AI in emergency rooms is getting way overhyped.

The therapy is part of a plan to develop gene therapies that can be efficiently delivered at lower doses, enabling them to be used against more than just “ultra-rare” conditions.

A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates